Literature DB >> 3742149

Excitatory effect of Clostridium perfringens alpha toxin on the rat isolated aorta.

Y Fujii, S Nomura, Y Oshita, J Sakurai.   

Abstract

Clostridium perfringens alpha toxin caused contraction of the isolated aorta of the rat in a dose-dependent manner. The contractile action caused by the toxin was inhibited or abolished by calcium antagonists such as nifedipine, verapamil and cinnarizine, or a Ca-free medium, but was not affected by phentolamine, chlorpheniramine, atropine, tetrodotoxin or a low Na medium. The toxin stimulated Ca uptake into the aorta in a dose-dependent manner. 8-N,N'-diethylaminooctyl-3,4,5-trimethoxybenzoate (TMB-8) blocked significantly both the toxin- and noradrenaline (NA)-induced contractions. Trifluoperazine (TFP) and N-(6-aminohexyl)-5-chloro-1-naphtharene sulphonamide (W-7) did not affect the contractile activity of the toxin but blocked the NA-induced contraction. The toxin also stimulated the 32P phosphate labelling of phosphatidylinositol (PI) and phosphatidic acid (PA) in the preparation. These results indicate that the toxin-induced contraction, which is different from that induced by NA, is the result of a direct action of the toxin on the aorta and is due to an increased Ca2+ permeability across the smooth muscle membrane. It is suggested that the contractile response to the toxin is associated with activation of phospholipid metabolism and enhanced entry of Ca into the aorta.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742149      PMCID: PMC1916981          DOI: 10.1111/j.1476-5381.1986.tb10233.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

Review 1.  Inositol phospholipids and cell surface receptor function.

Authors:  R H Michell
Journal:  Biochim Biophys Acta       Date:  1975-03-25

2.  Purification of Clostridium perfringens phospholipase C (alpha-toxin) by affinity chromatography on agarose-linked egg-yolk lipoprotein.

Authors:  T Takahashi; T Sugahara; A Ohsaka
Journal:  Biochim Biophys Acta       Date:  1974-05-10

3.  The effect of calcium on the skeletal muscle membrane after treatment with phospholipase C.

Authors:  E X Albuquerque; S Thesleff
Journal:  Acta Physiol Scand       Date:  1968-03

4.  Effect of Clostridium perfringens alpha toxin on the isolated rat vas deferens.

Authors:  J Sakurai; S Nomura; Y Fujii; Y Oshita
Journal:  Toxicon       Date:  1985       Impact factor: 3.033

5.  Mode of cytotoxic action of pseudomonal leukocidin on phosphatidylinositol metabolism and activation of lysosomal enzyme in rabbit leukocytes.

Authors:  T Hirayama; I Kato
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

6.  Effect of Clostridium perfringens alpha toxin on the cardiovascular system of rats.

Authors:  J Sakurai; Y Oshita; Y Fujii
Journal:  Toxicon       Date:  1985       Impact factor: 3.033

7.  Selective alpha 1- and alpha 2-adrenoceptor agonist-induced contractions and 45Ca fluxes in the rat isolated aorta.

Authors:  T Godfraind; R C Miller; J S Lima
Journal:  Br J Pharmacol       Date:  1982-12       Impact factor: 8.739

8.  Relationship between anti-diarrheal activity and binding to calmodulin.

Authors:  J H Zavecz; T E Jackson; G L Limp; T O Yellin
Journal:  Eur J Pharmacol       Date:  1982-03-12       Impact factor: 4.432

9.  Phosphatidate and oxidized fatty acids are calcium ionophores. Studies employing arsenazo III in liposomes.

Authors:  C Serhan; P Anderson; E Goodman; P Dunham; G Weissmann
Journal:  J Biol Chem       Date:  1981-03-25       Impact factor: 5.157

10.  Phospholipidcholesterol membrane model. Control of resistance by ions or current flow.

Authors:  J M TOBIAS; D P AGIN; R PAWLOWSKI
Journal:  J Gen Physiol       Date:  1962-05       Impact factor: 4.086

View more
  10 in total

1.  High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain.

Authors:  M Nagahama; J Sakurai
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 2.  Bacterial phospholipases C.

Authors:  R W Titball
Journal:  Microbiol Rev       Date:  1993-06

3.  Site-specific mutagenesis of Clostridium perfringens alpha-toxin: replacement of Asp-56, Asp-130, or Glu-152 causes loss of enzymatic and hemolytic activities.

Authors:  M Nagahama; T Nakayama; K Michiue; J Sakurai
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Phospholipid metabolism induced by Clostridium perfringens alpha-toxin elicits a hot-cold type of hemolysis in rabbit erythrocytes.

Authors:  S Ochi; K Hashimoto; M Nagahama; J Sakurai
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  Regulation of Clostridium perfringens alpha-toxin-activated phospholipase C in rabbit erythrocyte membranes.

Authors:  J Sakurai; S Ochi; H Tanaka
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Hemolytic and sphingomyelinase activities of Clostridium perfringens alpha-toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway.

Authors:  R W Titball; D L Leslie; S Harvey; D Kelly
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

7.  Evidence for coupling of Clostridium perfringens alpha-toxin-induced hemolysis to stimulated phosphatidic acid formation in rabbit erythrocytes.

Authors:  J Sakurai; S Ochi; H Tanaka
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Contraction of the rat isolated aorta caused by Clostridium perfringens alpha toxin (phospholipase C): evidence for the involvement of arachidonic acid metabolism.

Authors:  Y Fujii; J Sakurai
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

9.  Site-directed mutagenesis of histidine residues in Clostridium perfringens alpha-toxin.

Authors:  M Nagahama; Y Okagawa; T Nakayama; E Nishioka; J Sakurai
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

10.  Clostridium perfringens α-toxin impairs erythropoiesis by inhibition of erythroid differentiation.

Authors:  Teruhisa Takagishi; Masaya Takehara; Soshi Seike; Kazuaki Miyamoto; Keiko Kobayashi; Masahiro Nagahama
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.